RecruitingNCT06227611
Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.
Sponsor
Fondazione G.B. Bietti, IRCCS
Enrollment
16 participants
Start Date
May 4, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is comparing different types of visual field tests to find the best way to detect central vision loss in patients with glaucoma. Researchers are using eye scans (OCT) to measure nerve cell thickness alongside the vision tests.
**You may be eligible if...**
- You have been diagnosed with glaucoma with signs of optic nerve damage
- Your OCT scan shows reduced thickness of the ganglion cell layer in your eye
**You may NOT be eligible if...**
- You are under 18 years old
- You cannot read, understand, or sign the consent form
- You cannot perform a visual field test
- Your glaucoma is very advanced (cup-to-disc ratio over 0.7)
- You have other causes of optic nerve damage, retinal diseases, or significant cataracts/corneal clouding
- You have a significant refractive error (nearsightedness/farsightedness over ±6D, or astigmatism over ±3D)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06227611
Related Trials
Dresden Glaucoma and Treatment Study (DGTS)
NCT029592421 location
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
NCT07770685
Functional and Structural Imaging for Glaucoma
NCT019572671 location
Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression
NCT05940623
Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma
NCT07802769